
Bestselling author Colleen Hoover is sharing a health update with her many readers and fans.
The "It Ends with Us" author revealed she was diagnosed with cancer and underwent treatment in an Instagram story photo post Monday, writing, "Second to last day of radiation! I wish I could blame my hair and facial expressions on @texas.oncology but they've been great. Hope you never need them, but highly recommend them."
In an earlier Facebook post on Friday, Hoover wrote that she had received test results back from a geneticist that explained her cancer did not stem from "family genes" and was not tied to HPV or hormonal factors.
More people are living 5 years after cancer diagnosis, new data shows
She added that she was "happy and grateful to be alive."
Hoover has not revealed the type of cancer with which she was diagnosed.
The author was noticeably absent from the October 2025 premiere for the movie "Regretting You," which was adapted from her 2019 book of the same name.
"I'm super bummed, but am having an unavoidable surgery and can't travel for a while," Hoover wrote in an Instagram post at the time.
Hoover's latest book, "Woman Down," is out Jan. 13.
LATEST POSTS
- 1
Coca-Cola Co. and bottlers to invest in South Africa operations - 2
Israel violated ceasefire with Hezbollah more than 10,000 times, UNIFIL claims - 3
Wolf Bites Woman in Shocking Attack at Busy Shopping Center - 4
CVS forecasts 2026 profit above estimates on strong performance - 5
Hundreds of Gazans evacuated from Strip for medical treatment - COGAT
Manual for 6 famous sorts of cheddar
Ukraine's new defense minister just outlined how dire its troop shortage has become
The Minimized Passage Horse: Reconsidering a Symbol for the Cutting edge Period
Best Streaming Gadget for Your Home Theater
Poland Crypto Bill Clears Sejm Again, Defying President — Will “Restrictive” Rules Stick?
Plans for ‘stop anywhere’ night buses recommended by government for women’s safety
Ethiopian earthquakes and volcanic eruptions: earth scientist explains the link
ByHeart sued over recalled formula by parents of infants sickened with botulism
Roche breast cancer pill cuts risk of disease recurrence by 30% in trial












